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608: Antioxidants, folate and MTHFR polymorphism
studies in acute lymphoblastic leukemia (ALL)
1K. Chandrakumar, 2P. Chinnaswami
1Kongunadu Arts and Science College, G.N. Mills Post, Coimbatore
641029, Tamilnadu, India, 2Dr. N.G.P. Arts and Science College,
Dr. NGP Nagar, Kallapatti Road, Coimbatore 641035, Tamilnadu,
India
Acute leukemia (AL) is the most common cancer in children repre-
senting about one half of all cancers among persons younger than
15 years. Acute lymphoblastic leukemia (ALL) and acute myeloid
leukemia (AML) each represent a heterogeneous complex of disor-
ders, which result from diverse mechanisms of leukemogenesis. In
ALL, research is being increasingly placed on the elucidation of the
etiological factors and mechanisms involved in the disease develop-
ment. Since Leukemia’s are malignancies arising from rapidly
proliferating clones of haemotopoietic cells, thus having greatest
requirements for DNA synthesis, attention has recently been focused
on the genes or environmental factors that can play a role in an indi-
vidual’s susceptibility to DNA damage. Oxidants play a role in several
stages of carcinogenesis. Production of reactive oxygen species (ROS)
is an inevitable result in cells that use aerobic metabolism for energy
production. ROS can be important mediators of damage to biomole-
cules such as DNA, proteins, and lipids, leading to cellular dysfunction
and cell death. Accumulation of such molecules causes noxious effects
on individuals, resulting in diseases such as hematopoietic malig-
nancies. Folate, a key element in the one-carbon group metabolism, is
essential for normal mammalian cell growth. The folate metabolic
pathway is crucial in purine and pyrimidine synthesis, as well as in the
provision of methyl groups for DNA, RNA and protein methylation.
Disruption of homeostasis in the one-carbon pool, has been shown to
affect the risk of several cancers. Alterations in this metabolic pathway
can occur due to genetic variation at any of the enzymes directly
involved in maintaining homeostasis of the one carbon pool. Methy-
lenetetrahydrofolate reductase (MTHFR) is a central enzyme in the
metabolism of folate and methionine, both important factors inme-
thylation and DNA synthesis in humans. The enzyme catalyzes the
irreversible conversion of 5,10-methylenetetrahydrofolate to 5-meth-
yltetrahydrofolate, and it has been shown that the reduction in its
activity resulting from polymorphism in the MTHFR gene can modify
the susceptibility to cancer. Our studies focused on the antioxidant,
immunophenotyping and MTHFR polymorphism in acute lympho-
blastic leukemia (ALL) children. From our results it shows the
antioxidant levels were significantly reduced, folate levels and
MTHFR polymorphism shows the protection against ALL.
609: Relationship between down-regulated expression
of motility-related protein-1 (MRP-1/CD9)
and characteristics of gastric cancer
Xin Geng, Wang Fei, Zhang Wei-ming
Tianjin Medical University, 22 Qixiangtai Road, Heping District,
Tianjin, China
Objective: To explore and identify genes related to gastric cancer and
its premalignant lesions, and to analyze expression profiles of the
differentially expressed genes.
Methods: The differentially expressed cDNA bands were assayed by
fluorescent mRNA differential display (FDD) from gastric cancer
specimens, matched with normal gastric mucosa and premalignant
lesions. The mRNA expression of motility-related protein-1 (MRP-1/
CD9) gene was studied by RT-PCR and Northern blotting in different
kind of gastric tissue. The protein expression of MRP-1/CD9 was
assayed by Western blotting.
Results: In contrast, a differentially expressed cDNA fragment named
G1, exhibited lower expression in all gastric cancers compared to the
matched normal gastric mucosa and premalignant lesions. A BLASTN
search for sequence homology performed in the GenBank revealed that
the sequence of G1 was identical (100% homology) to that of the 30 end
of human MRP-1/CD9 mRNA. Northern blotting analysis confirmed
the differential expression of MRP-1/CD9. RT-PCR analysis showed
that the MRP-1/CD9 gene was expressed at much lower rate in gastric
cancer (0.31 ± 0.18) compared to the matched normal gastric tissue
(0.49 ± 0.24) (P = 0.001) and premalignant lesions (0.47 ± 0.18)
(P = 0.041). Furthermore, MRP-1/CD9 mRNA expression in diffuse-
type of gastric cancer (0.22 ± 0.17) was much lower than that
expressed in intestinal-type of gastric cancer (0.38 ± 0.16)
(P = 0.015). Western blotting analysis showed that the MRP-1/CD9
protein was expressed at much lower rate in gastric cancers
(0.21 ± 0.13) compared to the matched normal gastric tissue
(0.46 ± 0.19) (P = 0.001) and premalignant lesions (0.42 ± 0.14)
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(P = 0.001). MRP-1/CD9 protein expression in diffuse-type of gastric
cancer (0.20 ± 0.11) was much lower than that expressed in intestinal-
type of gastric cancer (0.39 ± 0.12) (P = 0.002).
Conclusion: The MRP-1/CD9 expression was down-regulated in
gastric cancer and its expression may be related to the carcinogenic
process and histological type of gastric cancer.
610: Amyotrophic lateral sclerosis: a promising
therapeutic approach, from laboratory to clinical
implications
G. Nagesh Babu, Alok Kumar
Department of Neurology, SGPG Institute of Medical Sciences,
Raebareli Road, India
Amyotrophic lateral sclerosis (ALS) is a late-onset progressive
degeneration of motor neurons occurring both as a sporadic and a
familial disease. The etiology of ALS remains unknown, but one fifth
of instances are due to specific gene defects, the best characterized of
which point mutations in the gene is coding for Cu/Zn superoxide
dismutase (SOD1). Because sporadic and familial ALS affects the
same neurons with similar pathology, it is hoped that understanding
these gene defects will help in devising therapies effective in both
forms. A wealth of evidence has been collected in rodents made
transgenic for mutant SOD1, which represent the best available model
for familial ALS. Mutant SOD1 likely induces selective vulnerability
of motor neurons through a combination of several mechanisms,
including protein misfolding, mitochondrial dysfunction, oxidative
damage, cytoskeletal abnormalities and defective axonal transport,
excitotoxicity, inadequate growth factor signaling, and inflammation.
Damage within motor neurons is enhanced by noxious signals origi-
nating from nonneuronal neighboring cells, where mutant SOD1
induces an inflammatory response that accelerates disease progression.
We observed that lipid peroxidation in the erythrocytes of amyotrophic
lateral sclerosis patients significantly increased with respect to con-
trols. On the other hand, catalase activity was found to be significantly
lower. The activities of glucose-6-phosphate dehydrogenase, gluta-
thione reductase and glutathione levels were also found to be
significantly reduced in ALS patients compared to healthy subjects. It
was further observed that lipid peroxidation started to increase and
catalase, glutathione reductase, glucose-6-phosphate dehydrogenase
enzyme activities and glutathione levels started to decrease as amyo-
trophic lateral sclerosis progressed from 6 to 24 months, suggesting a
correlation between these parameters and duration of amyotrophic
lateral sclerosis. This study confirms the involvement of oxidative
stress during the progression of amyotrophic lateral sclerosis and the
need to develop specific peripheral biomarkers. The clinical implica-
tions of these findings may lead to promising therapeutic approaches.
611: Drug target prioritisation from metabolic
pathways
Andrew Lynn, Dhwani Desai, Soumyadeep Nandi
Jawaharlal Nehru University, New Delhi, India
The process of drug discovery for pathogenic infections has under-
gone a paradigm shift in the last two decades. Target identification
and lead discovery/optimisation are two of the main components of
the drug discovery cycle where computational strategies have had
maximum impact. Rational methods for drug design have replaced
screening and serendipity, shifting the process of discovery to iden-
tification of novel drug targets from pathogenic organisms. The
development of a pipeline which can link drug discovery from drug
target identification to inhibitor design is desirable especially in the
post-genomic era where complete genome sequencing projects have
greatly facilitated the process of unraveling the full repertoire of
biological functions that an organism possesses. For a pathogenic
organism, such a compilation of functions has a direct implication in
discovering potential drug targets, for example, identifying virulence
factors, searching for membrane transporters or uncharacterised genes
which are conserved across a large number of genomes, selecting
genes or functions which are unique to the pathogen and not present
in the host organism etc. We have applied a method developed in-
house, which uses function specific Hidden Markov models for
accurate identification of metabolic enzymes from genome sequences.
This protocol, ModEnzA, incorporates sequence clustering and
enrichment of the training sequences. We compare our method with
other enzyme identification methods, namely PRIAM, MetaShark
and EFICAz for genome-wide enzyme identification in E. coli,
B. aphidicola, M. pneumoniae and P. falciparum genomes. ModEnzA
outperforms the other methods in terms of specificity and sensitivity.
The ModEnzA protocol is applied for enzyme identification from 664
bacterial genomes. Potential drug targets are prioritized from the list
of metabolic enzymes using graph-theoretic representations of met-
abolic networks. We prioritise drug targets in terms of chokepoints
(those enzymes which either produce and/or consume a unique
metabolite), breakpoints (enzymes whose removal from the metabolic
network results in an increase in the number of strongly connected
components) and the presence/absence of alternate pathways that can
circumvent a deleted enzyme in the metabolic network. We apply this
protocol for generating lists of potential drug targets from the
pathogens M. tuberculosis and P. falciparum.
612: SimOrg—a novel computational software
for system variable analysis
Dhawal Moghe
C/o Dr. Rama Vaidyanathan, Department of Industrial
Biotechnology, Dr. MGR Educational and Research Institute,
Maduravoyal, Chennai (Tamil Nadu), India
Aim: The aim of this project was to develop an indigenous and ori-
ginal software program which could be used to model various systems
e.g. life processes of organisms using a mathematical approach—an
algorithm which could be input by the end-user and the software
would show the changing values in the form of a graphical repre-
sentation. The various parameters can give a detailed ‘analytical’
overview concerning the life processes of the organisms and their
related variables. Analysis of variables in a system is always a fun-
damental problem for many bioinformatics case-studies and other
procedures. If a basic model of system’s variables can be determined
empirically or theoretically, then one invariably needs a simulation
platform on which to run the algorithm. SimOrg is a novel software
which achieves this, and much more.
The main idea: When in a certain area (Array), a particular Organism/
System/Unit exists in a particular region (Cell), its survival may
depend on certain factors such as Locomotion, Reproduction, Intel-
ligence etc. These factors usually depend circularly on each other e.g.
more Intelligence may mean more levels of Locomotion; which in
turn may imply a bit lower Reproduction efficiency. This behavior of
Organisms or a Unit can be roughly simulated through mathematical
expressions, if they have been already established or found out. It
should be noted that the variable types mentioned here like Loco-
motion, Reproduction etc. are just for representative purposes only
and for the correct running of the program with default values. The
end-user may propose any other model with different variables too; so
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that an entirely new system may be simulated. In addition to this,
these Organisms/Units may also get affected by the external changes
in the environment. These external factors may change randomly and
may not get significantly affected by the Organisms. But they do have
their affects on the Organisms’ life parameters.
Coding environment: The software was made and compiled for final
distribution as an exe file using the registered copy of developing
environment of Game Maker 6.0, a freeware utility for making Games
and other Software.
613: Integration of genomic expression data into the
etiopathogenetic clusters—important step in teaching/
learning of medicine
Zdenko Kovac
Department Pathophysiology Medical Faculty, University of Zagreb,
KBC Kispaticeva 12, Zagreb, Croatia
The exponential growth of information, nonlinear behavior of pathobi-
ological system and increasing complexities of conceptual models have
imposed the unique demands on educational system and methodology in
medicine. Comprehensive enrichment of classical human pathophysi-
ology with the genomic data is still pending issue. Powerful computing
systems, sophisticated morphological methods and postgenomic
throughput quantities of molecular data are providing new insights into
the processes underlying clinical presentations. On the other side, stu-
dents and practicing doctors are inclined to limit their scope to the given
branch within the system of compartmentalized medicine. Educational
curricula are often designed according to the similar pattern. Evidence
based medicine may be considered as the attempt to bridge the chasm of
contemporary medicine. Pathophysiological interpretations of natural
history of diseases and disorders aim to integrate vertical dimension
(from the molecule to symptom), horizontal dimension (simultaneous
involvement of multiple systems), as well as longitudinal dimension
(natural course) of the problem. In order to achieve such integration, we
have been using a matrix-designed, problem-solving educational model.
This model contains four steps. Exposition of problem (1), repetition of
knowledge (2), algorhythmic workout (3), and feedback integration of
the problem (4) reiterate and put together the heterogeneous facets of the
same issue. The etiopathogenetic pathways are outlined as dominant,
contextual, parallel, and sequential, as well as the branching points. This
four-step approach clearly depicts etiopathogenetic pathways and net-
works of interconnected elements within the hierarchy of the system.
Some nodes within the networks (e.g., disturbed gene expression,
structural alterations, concentration abnormalities, etc.) form the clusters,
with multiple entries and outputs. Focusing to such clustering points may
become a reliable approach to master complexities in medicine. Relevant
genomic data are molecular pillars of such clusters. Both qualitative and
quantitative aspects of gene expression are adding up to classical inter-
pretations. Since this model is the opened matrix, new data can be easily
incorporated at the appropriate place. They are corroboration and/or
challenging information within the context of networks of hierarchical
system. Basic etiopathogenetic pathways and clusters are enforced and
solidified into reliable framework of pathobiological processes.
614: Tricentric Y chromosome mosaicism in a Turner
syndrome—clinical cytogenetic and molecular studies:
a new case report
1D. S. Krishna Murthy, 2S. K. Murthy, 1A. Ghosh, 3K. Jayarama,
3S. Shetty, 4C. Ramamurthy, 4T. Rajaram, 1N. Jayasuryan
1Microtest Innovations Pvt Ltd, G-05, Discoverer, Tech Park Mall
ITPL, Bangalore, India, 2Genetics Department, Al Wasl Hospital,
DOHMS, Dubai, United Arab Emirates, 3Centre for Human Genetics,
G-04 Tech Park Mall, ITPL, Bangalore, India, 4Department of Obst
and Gynecology and Pathology, Apollo Hospital, Bannerghatta Road,
Bangalore, India
We report here a new case of Turner syndrome with a ‘‘tricentric Y
chromosome’’ mosaicism. The proband, a 21 year-old female with h/o
primary amenorrhoea and very few clinical features of typical Turner
syndrome, was investigated to rule out Turner syndrome. Routine
chromosome analysis from peripheral blood culture using G-banding
technique showed mos 45,X/46,X,der(Y) [75;25]. A few cells with
iso(Yp) [4%] and 47,X,der(Y), + ring(Y) [1] were also observed. FISH
analysis using Centromeric probes for X and Y chromosome, WCP Y
(heterochromatin) and SRY confirmed one X chromosome and the
derivative Y chromo with three centromeres (CEP Y +++) and two
copies of SRY. PCR analysis of the genomic DNA confirmed positive
for SRY (Yp11.3), ZFX/Y (Yp11.3/Xp22.3-p21.3), AZFa (Yq11.21),
AZFb((Yq11.22) and AZFc(Yq11.23). Karyotype of the mother is
normal 46,XX. Father and an elder brother of the proband were not
available for investigation. Histopathology of bilateral streak gonads
(both left and right) showed atrophic tubules containing only sertoli
cells (Testicular tissue). No gonadoblastoma was observed. She is
responding well to HRT therapy. Despite the presence of a Y chro-
mosome and SRY gene (two copies), she did not show any signs of
virilization except for a reduced growth rate (Ht. 154 cm at 21 years).
Mosaicim for dicentric Y chromosome, iso Yp or iso Yq or known in
Turner syndrome cases with a derivative Y chromosome. However,
tricentric Y chromosome has not been reported in the literature. This is
the first report of a TRICENTRIC Y chromosome to the best of our
knowledge. There are only four cases of tricentric chromosome
reported in the literature (Chromosomes 9, 15, Acrocentric chromo-
somes and X—Borgaonkar DS, chromosomal variation in man—
online database, Wiley, 2008). The clinical significance the mosaicsm
and origin of the tricentric Y chromosome will be presented.
615: Risk assessment of drug-like molecules by in-silico
quantitative structure toxicity relationships
1Ashwini Mohan, 2Karthikeyan Muthukumarasamy
1Vel’s College of Science, P.V. Vaithiyalingam Road, Pallavaram,
Chennai 600 117, India, 2National Chemical Laboratory, Homi Bhaba
Road, Pune 411 008, India
In the early stage of drug discovery, especially for computer-aided
design, a large number of molecules will be proposed as potential
leads and that the bioactivity risk of these molecules is expected to be
evaluated prior to synthesis. The rule-based expert systems have been
used for the aim, while mining of a large amount of toxicological data
can provide us with another promise.
In the present study, an initial analysis to a toxicological database
of chemicals is made. Then a stepwise strategy is provided to
chemical data mining of toxic chemicals, which combine principles of
QSAR study with structure-activity clustering. QSTR (Quantitative
Structure Toxicity Relationship) predictive models were developed
using QSAR method with database of 612 compounds provided by
Environment Protection Agency (EPA). These models, which are
developed, allow prediction of acute toxicity (LC50) of chemical
compounds generally used for risk assessment of drugs prescribed and
environmental disaster management. The QSTR methods are fast,
economic and powerful screening tools, and also contribute to the
reduction of the animal use in biological activity studies. These
models were successfully tested by applying on the cancer database,
Genomic Med. (2008) 2:435–438 437
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which contained molecules elucidated on the basis of scaffold-based
approach. This helped to evaluate the extent of toxicity of active
molecules in the cancer database. Thus this approach promises a good
risk assessment model to predict toxicity for any dataset containing
active drug molecules.
616: Association of ADH1B and ALDH2 gene
polymorphisms with alcohol dependence: a pilot study
Meera Vaswani, Pushplata Prasad
All India Institute of Medical Sciences, National Drug Dependence
Treatment Center, Department of Psychiatry, New Delhi, India
Background: Functional polymorphism in ADH1B and ALDH2 genes
are considered most important among several genetic determinants of
alcohol dependence (AD), a complex disorder.
Aims: There is no report on the widely studied Arg47His and
Glu487Lys polymorphisms from Indian alcohol dependent popula-
tion. We, for the first time, report allelic and genotypic frequencies of
Arg47His and Glu487Lys SNPs in North Indian alcohol dependent
subjects.
Methods: A total of n = 174 alcohol dependent males, recruited using
DSM IV criteria, were genotyped using PCR–RFLP method.
Results: Data obtained from genetic analysis was correlated with
clinical parameters using T test or Mann Whitney’s U test. ADH1B
gene polymorphism was found to be largely monomorphic with minor
allele frequency (ADH1B-2) less than 0.001. For the ALDH2
Glu487Lys SNP, genotypic frequencies were 0.73 (2-1/1), 0.16 (2-1/
2) and 0.11 (2-2/2), with minor allele frequency (ALDH2-2) = 0.19.
Various clinical parameters were found to be significantly associated
with ALDH2 polymorphism.
Conclusions: The highlight of the study is a clear association of
ALDH2 gene polymorphism with delayed onset and shorter duration
of alcohol consumption among ALDH2-2/2 individuals. Our finding
bolsters the protection conferring property of the ALDH2-2 allele of
Glu487Lys SNP of ALDH2 gene.
617: Synergistic interplay between Helicobacter pylori
virulence genes and host COX-2 and iNOS enhances
the risk of gastric cancer
1 Santosh Tiwari, 1Manoj Gopi, 1 G. Sivaram, 1 R. Saikanth,
2Zakia Abid, 1Aejaz Habeeb, 1Aleem Khan, 1Habibullah Mohammed
1Center for Liver Research and Diagnostics, Deccan College of
Medical Sciences, Kanchanbagh, Hyderabad, India, 2Department of
Pathology, Deccan College of Medical Sciences, Kanchanbagh,
Hyderabad, India
Background and Aim: H. pylori (Hp) strains vary in their carcino-
genic potential. Both host factors and bacterial factors have been
postulated to contribute to the variable outcome. Over expression of
host COX-2 (encoded by the PTGS2 gene) and iNOS (encoded by the
NOS2A gene) has been implicated in the development of gastric
carcinoma. Furthermore, the link between genotypes in relation
to COX-2 and iNOS expression and disease status needs to be
determined. Therefore the present study addressed to identify
Hp-bearing hosts who are at greatest risk of developing precancerous
lesions.
Methods: A total of 240 subjects with various gastric disorders were
screened. Genotyping based on cagA, cagE, cagT, vacA signal region
and hrgA genes of Hp was performed using DNA from gastric
biopsies. Expression of COX-2 and iNOS was assessed by RT-PCR
and immunoblotting. Histological scoring of antral and corpus
biopsies for the presence precancerous lesions was done.
Results: Genotype cagA?/cagE?/cagT?/hrgA?/vacAs1 showed
high prevalence 73.7%. Among which 81.1% had overt gastric dis-
orders whereas 46% subjects had less severe gastric disease.
Histology revealed presence of atrophy in 52 vs. 18%, IM in 32 vs.
9% and dysplasia in 20 vs. 4% respectively (Statistically significant at
p-0.01. RT-PCR and immunoblotting data showed high expression
patterns of COX-2 and iNOS in overt gastric disorders than with less
severe gastrointestinal disorders.
Conclusion: Genotype cagT?ve/hrgA?ve/cagA?ve/cagE?ve/vacAs1
?ve and heightened expression levels of COX-2 and iNOS have
higher differentiating and predictive value for the development of
severe disease manifestations. This suggests that Hp induced gastric
inflammatory reaction to be influenced by multiple factors, and
probably results from the synergistic effect of bacterial virulence and
host factors, which work together in a complex way causing various
diseases in the host.
618: Structure based drug designing for HIV-1 reverse
transcriptase protein
Nalin H. Maniya, Dharmesh H. Sur
VIT University, Vellore, Tamilnadu, 52-Subhash Park, Near Sarthana
Jakatnaka, Varacha road, Surat, Gugarat, India
Nevirapine and its structural derivatives are important non-nucleoside
HIV-1 reverse transcriptase inhibitors (NNRTIs). Nevirapine may
cause severe or life-threatening liver toxicity, usually emerging in the
first 6 weeks of treatment. The most common adverse effect of ne-
virapine is the development of mild or moderate rash. Severe or life-
threatening skin reactions have been observed in patients, including
Stevens-Johnson syndrome, toxic epidermal necrolysis and hyper-
sensitivity. Therefore there is a need and urge to develop a new drug
having minimum adverse effects and high effectiveness. In this work,
nine nevirapine analogues were studied. ChemSketch software was
used to design/draw new structural derivatives. VEGAZZ software
was used to dock nevirapine into its target (HIV-1 RT) and binding
energy in the form of energy score was developed. Out of nine
derivatives, substitution of H with CH3 at the different positions, as
well as substitution of O with S at the B position in analogues, were
found to be the most potent in comparison with the template nevi-
rapine (which is used currently as the drug candidate). All the
analogues also passed the absorption, distribution, metabolism and
excretion (ADME) screening and Lipinski’s rule of 5, and have the
potential to be used for second-generation drug development. The
work demonstrates that ChemSketch-VEGAZZ and ADME screening
(ADMETox) is a promising approach to predict the binding activity
of ligands to the receptor and further screen for a successful candidate
drug in a computer-aided rational drug design.
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